Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Screening performance of the FINDRISC score for identification of undiagnosed type 2 diabetes in persons with severe obesity.

Diabetology & metabolic syndrome·2026
Same author

Correction: Rosiglitazone modifies the adipogenic potential of human muscle satellite cells.

Diabetologia·2025
Same author

Corrigendum to "Implementing Occupational Therapy into an Acute Geriatric Ward: Effects on Patients' Functional Status at Discharge" [J Frailty Aging 13 (2024) 307-12].

The Journal of frailty & aging·2025
Same author

Implementing Occupational Therapy into an Acute Geriatric Ward: Effects on Patients' Functional Status at Discharge.

The Journal of frailty & aging·2024
Same author

Structure of the space of folding protein sequences defined by large language models.

Physical biology·2024
Same author

Which protocol for prostate biopsies in patients with a positive MRI? Interest of systematic biopsies by sectors.

Prostate cancer and prostatic diseases·2023
Same journal

Erratum to: Immunotherapeutic Approach to Cancer with Cutaneous DNA Vaccination.

Methods in molecular medicine·2015
Same journal

Methods for cancer gene therapy using tumor suppressor genes.

Methods in molecular medicine·2014
Same journal

Suppression of the human carcinoma phenotype by an antioncogene ribozyme.

Methods in molecular medicine·2014
Same journal

Methods for the use of stromal cells for therapeutic gene therapy.

Methods in molecular medicine·2014
Same journal

Methods for adenovirus-mediated gene transfer to synovium in vivo.

Methods in molecular medicine·2014
Same journal

Methods for gene transfer to synovium.

Methods in molecular medicine·2014
See all related articles

Related Experiment Video

Updated: Jun 3, 2026

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

CTL Analysis for Tumor Vaccines.

A Rosato1, G Milan, A Zambon

  • 1Department of Oncology and Surgical Sciences, University of Padova, Padova, Italy.

Methods in Molecular Medicine
|March 5, 2011
PubMed
Summary
This summary is machine-generated.

Researchers are exploring ways to boost the immune system to fight cancer. Strategies include enhancing cancer cell vaccines and using tumor-associated antigens (TAA) to train immune cells for tumor destruction.

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

Related Experiment Videos

Last Updated: Jun 3, 2026

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

Area of Science:

  • Immunology
  • Oncology
  • Cancer Research

Background:

  • Therapeutic immune responses against tumors are crucial for cancer treatment.
  • Cytotoxic T lymphocytes (CTL) are key players in tumor cell destruction.
  • Current research focuses on enhancing tumor immunogenicity and targeting tumor-associated antigens (TAA).

Purpose of the Study:

  • To review strategies for stimulating anti-tumor immune responses.
  • To highlight the role of CTL in cancer immunity.
  • To discuss methods involving tumor cell engineering and TAA-based immunization.

Main Methods:

  • Vaccination protocols using adjuvants or engineered tumor cells.
  • Immunization with tumor-associated antigens (TAA).
  • Gene insertion of TAA into viral vectors for host cell expression.
  • Immunization with purified TAA peptides or antigen-presenting cells.

Main Results:

  • Various approaches aim to increase the immunogenicity of cancer cells.
  • TAA can be recognized by CTL as peptides presented by MHC class I molecules.
  • Viral vectors and antigen-presenting cells are utilized for TAA delivery.
  • These methods aim to induce a targeted immune response against tumors.

Conclusions:

  • Stimulating a therapeutic immune response is a major goal in cancer research.
  • Both enhancing cancer cell immunogenicity and TAA-based strategies are promising.
  • Further development of these immunotherapeutic approaches is warranted for effective cancer treatment.